Recombinetics Announces New Board of Directors with Representatives from a Series A Strategic Investor: Gundersen Health System

Recombinetics today announced its new board of directors following this week’s completion of a $34 million Series A financing round. Gundersen Health System, a physician-led, not-for-profit healthcare system with locations in Wisconsin, Minnesota and Iowa, led the round as a strategic investor and now has three representatives on Recombinetics’ Board. [...]

Recombinetics Announces New Board of Directors with Representatives from a Series A Strategic Investor: Gundersen Health System2018-08-24T12:00:55-05:00

Recombinetics Closes $34 Million in Series A Funding

Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to [...]

Recombinetics Closes $34 Million in Series A Funding2022-02-28T09:20:54-06:00
Go to Top